Improving tuberculosis contact tracing: The role of evaluations in the home and workplace

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 1, 2012, Pages 55-59

  Duarte, Raquel ^a,b,c   Neto, M ^d   Carvalho, A ^a,b   Barros, H ^c  

^a CDP de Vila Nova de Gaia   (Portugal)

^b CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

^c University of Porto   (Portugal)

^d Administração Regional de Saúde ARS Norte   (Portugal)

Author keywords

Home visit; Screening; Tuberculosis; Workplace visit

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULIN;

ADULT; ARTICLE; CONTACT EXAMINATION; CONTROLLED STUDY; HEALTH PROGRAM; HOME ENVIRONMENT; HUMAN; INTERMETHOD COMPARISON; INTERVIEW; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; PORTUGAL; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORKPLACE;

CONTACT TRACING; GUIDELINE ADHERENCE; HOUSE CALLS; HUMANS; INTERVIEWS AS TOPIC; LATENT TUBERCULOSIS; MASS SCREENING; PORTUGAL; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; SOCIAL ENVIRONMENT; TIME FACTORS; TUBERCULOSIS; WORKPLACE;

EID: 84555194780     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0511     Document Type: Article

References (26)

1. Reichler M R, Reves R, Bur S, et al. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 2002; 287: 991-995. (Pubitemid 34252056)
2. Marks S M, Taylor Z, Qualls N L, et al. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 2000; 162: 2033-2038. (Pubitemid 32051659)
3. Reichler M R, Reves R, Bur S, et al. Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States. Southern Med J 2002; 95: 414-420. (Pubitemid 34286737)
4. Centers for Disease Control and Prevention. Essential components of a tuberculosis prevention and control program: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1995; 44 (RR-11): 2.
5. National Health Service. Sistema de Vigilância da Tuberculose (SVIG-TB). Lisbon, Portugal: National Health Service, 2009.
6. Duarte R, Amado J, Lucas H, Sapage J M; Portuguese Society of Pulmonology. [Treatment of latent tuberculosis infection: update of guidelines, 2006.] Rev Port Pneumol 2007; 13: 397-418. [Portuguese]
7. Comstock G W, Livesay V T, Woolpert S F. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99: 131-138.
8. Vynnycky E, Fine P E. Lifetime risks, incubation period and serial interval of tuberculosis. Am J Epidemiol 2000; 152: 247-263. (Pubitemid 30640248)
9. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of preventive therapy for tuberculosis: five years of follow up in the IUAT trial. Bull World Health Organ 1982; 60: 555-564.
10. Iseman M D. Containment of tuberculosis. Preventive therapy with isoniazid and contact investigation. Chest 1979; 76 (Suppl): S801-S804.
11. Reichler M R, Reves R, Bur S, et al.; Contact Investigation Study Group. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 2002; 287: 991-995. (Pubitemid 34252056)
12. Bock N, Mallory J P, Mobley N, DeVoe B, Taylor B B. Outbreak of tuberculosis associated with a floating card game in the rural south. Clin Infect Dis 1998; 27: 1221-1226.
13. Mangura B T, Napolitano E C, Passannante M R, et al. Mycobacterium tuberculosis miniepidemic in a church gospel choir. Chest 1998; 113: 234-237. (Pubitemid 28044952)
14. Centers for Disease Control and Prevention. HIV-related tuberculosis in a transgender network: Baltimore, Maryland, and New York City area, 1998-2000. MMWR Morb Mortal Wkly Rep 2000; 49: 317-320.
15. Fitzpatrick L, Hardacker J, Heirendt W, et al. A preventable TB outbreak investigated through an intricate social network. Clin Infect Dis 2001; 33: 1801-1806. (Pubitemid 33105117)
16. Howard J, Paranjothy S, Thomas S, Bracebridge S, Lilley M, McEvoy M. Outbreak of tuberculosis in a junior school in south-eastern England. Euro Surveill 2007; 12: E070628.1.
17. Duarte R, Tavares E, Miranda A, Carvalho A. Tuberculosis in a child - search for the infected adult nearby; case report, Portugal, 2007. Euro Surveill 2009; 14: pii: 19326.
18. National Tuberculosis Controllers Association, Centers for Disease Control and Prevention (CDC). Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep 2005; 54 (RR-15): 1-47.
19. Li J, Munsiff S S, Tarantino T, Dorsinville M. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis 2010; 14: e292-e297.
20. Hirsch-Moverman Y, Bethel J, Colson P W, Franks J, El-Sadr W. Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience. Int J Tuberc Lung Dis 2010; 14: 1104-1111.
21. Anibarro L, Casas S, Paz-Esquete J, et al.; Mycobacteria Study Group (GEIM) of Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Treatment completion in latent tuberculosis infection at specialist tuberculosis units in Spain. Int J Tuberc Lung Dis 2010; 14: 701-707.
22. Horsburgh C R Jr, Goldberg S, Bethel J, et al.; Tuberculosis Epidemiologic Studies Consortium. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest 2010; 137: 401-409.
23. Trajman A, Long R, Zylberberg D, Dion M J, Al-Otaibi B, Menzies D. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment. Int J Tuberc Lung Dis 2010; 14: 551-559.
24. Ziakas P D, Mylonakis E. 4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on adherence and liver toxicity. Clin Infect Dis 2009; 49: 1883-1889.
25. Pisu M, Gerald J, Shamiyeh J E, Bailey W C, Gerald L B. Targeted tuberculosis contact investigation saves money without sacrificing health. J Public Health Manag Pract 2009; 15: 319-327.
26. Bailey W C, Gerald L B, Kimerling M E, et al. Predictive model to identify positive tuberculosis skin test results during contact investigations. JAMA 2002; 287: 996-1002. (Pubitemid 34252057)